(Date:1/7/2009)...WellPoint, Inc. (NYSE: WLP ) announced,today tha... 27th Annual J.P.,Morgan Healthcare Conference on ...(12:30 p.m. Eastern Standard Time). , WellPoin...or the three,months ended Dec. 31, 2008, on Januar...t period prior to this scheduled earnings release,...
(Date:1/7/2009)...dical Enterprises, Inc. (BME), a cutting edge medi...rthopaedic memory metal implants, announced today ...dent and Chief Executive Officer. W. Casey Fox, P...ogy Officer and continue to focus his efforts on b...BME specializes in nitinol implants that contract ...
(Date:1/7/2009)... have double the troubles of those born at 39 week...-- Women having an elective repeat C-section shoul...pregnancy to have the baby, if there are no medica...d. , Delivering just two weeks earlier doubles th...rouble breathing, infection and low blood sugar, a...
(Date:1/7/2009).... 7 SB 203, known as Emily,s Law, has received Go...e law official in the state of Ohio. Named after E...ements and regulations for pharmacy technicians. T...Tim Grendell, was drafted with assistance of the N...ly,s Story , Emily Jerry died at the age of two a...
Breaking Medicine News(10 mins):Health News:WellPoint Announces Appearance at Upcoming Conference 2Health News:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer 2Health News:Early Elective C-Sections Produce Complications 2Health News:Early Elective C-Sections Produce Complications 3Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 2Health News:Emily's Law for Regulating Pharmacy Technicians Signed by Ohio Governor 3...tential flu pandemic showed that nearly 62 million...ileged nations, could pay// with their life. The... Spanish flu, which wiped out nearly 20 million pe...om the Harvard School of Public Health and the Uni...
... pain are effective, a new review of studies has f...ogical outcomes such as// depression and health-re...experience of pain. “Because this analysis was b...ive than previous reviews, we have the best eviden...
...ient may be forced to undertake treatment in spite... painful radiotherapy. Having beaten the condition...nning over six years, Leah has been confronted by ... to her parents Kathryn and Mark Richards, the att...
...atry published a study which proved that Botox- th...ting wrinkled skin could ease writer’s cramp as we... contractions of the hand, arms or fingers which c...ur during manual work. Some people learn to write ...
Other Medicine News:Health News:Psychological Treatments Improve Outcomes for Back Pain Sufferers 2Health News:Psychological Treatments Improve Outcomes for Back Pain Sufferers 3(Date:1/7/2009)..., Late Preterm Infants Drive the Increase , ,.../ -- New government statistics confirm that the de... rate continues, putting more infants than ever at...to the March of Dimes. , , Nearly 543,000 babie...ional Center for Health Statistics, which today re...
(Date:1/7/2009)..., OXFORD, England, January 7 ...pany focused on allergy and critical care, today,...ts achieved in 2008 with,its ToleroMune(R) anti-a...patient recruitment for a further phase II clinica...way in Canada, has recruited 120 patients with con...
(Date:1/6/2009)..., NEW YORK, Jan. 6 Th...ut $2.7 million to four industry research teams fo...s for Parkinson,s disease. , , The funding was ...opment Initiative. This program, first launched i...orts on Parkinson,s research. TDI is part of MJF...
(Date:1/6/2009)..., PARIS, France, January 6 /PRNewswire-First... to Extend the Collaboration Until,December 2011 ...tion to Include Antibody,Discovery in Ophthalmolo...s to ExonHit if Allergan,Sublicenses to a Third P...LEHT) today announced a reinforcement,of its exis...
Breaking Medicine Technology:Preterm Births Rise 36 Percent Since Early 1980s 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Michael J. Fox Foundation Awards $2.7 Million to Four Industry Teams for Pre-Clinical Parkinson's Disease Research 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 2ExonHit Therapeutics Expands Strategic Collaboration With Allergan 3ExonHit Therapeutics Expands Strategic Collaboration With Allergan 4Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 17828 1Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 17828 2Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 17828 3Thermage Inc Announces First Quarter 2008 Results Release Date and Conference Call 17826 1Clinical Update Debio 025 in Hepatitis C 1907 1Clinical Update Debio 025 in Hepatitis C 1907 2Clinical Update Debio 025 in Hepatitis C 1907 3NAMI 3A Women and Depression 3B 1 in 8 in Their Lifetime 3B Twice the Rate of Men 17822 1NAMI 3A Women and Depression 3B 1 in 8 in Their Lifetime 3B Twice the Rate of Men 17822 2...S WIRE)--May 14, 2007 - Oculus Innovative,Sciences...cyn,Technology was the subject of a poster present... (EWMA) conference that was held in,Glasgow, Scotl... Results About an Antimicrobial,Solution in the Tr...ng & Harding infection criteria to evaluate th...
...-May 15, 2007 - Gemin X Biotechnologies,Inc. annou...Blood,demonstrated that its lead compound, obatocl...le Cell Lymphoma (MCL) cell lines and,primary cell...small,molecule specifically designed to inhibit al...validated cancer target, thus restoring,the natura...
Other Medicine Technology:Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 2Oculus Innovative Sciences Microcyn Technology Presented in Poster,at European Wound Management Association Conference 3Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 2Gemin X Biotechnologies Announces Publication in Blood of Positive,Preclinical Data of Lead Compound in Mantle Cell Lymphoma 3...ttors , , Available with five different volume ra...ors can effectively meet the demands of any applic...nd superior functionality as our multichannel line...a wide range of liquid handling tasks including:,...
... high performance electronic pipetting!, Soft, f...educe hand fatigue and strain , Stress-free tip ...ding for easy volume identification , Accepts un...on AdvanTip Low Retention and AdvanTip Precision P...
... high performance electronic pipetting! , Soft, ...reduce hand fatigue and strain, Stress-free tip ...ing for easy volume identification, Accepts univ... AdvanTip Low Retention and AdvanTip Precision Pip...
The Finnpipette BioControl is a major step forward in electronic pipetting technology. A complete liquid handling system - with one universal handle and twelve interchangeable tip cone modules. All f
Medicine Products: